CCR5 and HIV infectious disease: Individuals with a 32 base pair deletion in their CCR5 gene (Δ-32) have reduced CCR5 expression on the surface of their CD4+T cells, and achieve full (homozygous) or partial (heterozygous) protection against HIV infection [12]–[15].